INOVIO PHARMACEUTICALS INC shareholders Q3 2023

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
Mayflower Financial Advisors, LLC 30,953$12,0410.00%
D. E. Shaw & Co., Inc. 5,518,837$2,146,8280.00%
Covestor Ltd 4,002$20.00%
TWO SIGMA INVESTMENTS, LP 829,238$322,5740.00%
Farther Finance Advisors, LLC 10,455$4,0670.00%
TUDOR INVESTMENT CORP ET AL 226,021$87,9220.00%
Verition Fund Management LLC 300,045$116,7180.00%
VALLEY NATIONAL ADVISERS INC 7,655$30.00%
ACADIAN ASSET MANAGEMENT LLC 460,200$1780.00%
MEANS INVESTMENT CO., INC. 10,013$3,8950.00%
External links

This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q3 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.